SCHEMBL5040802

SCHEMBL5040802

COC(C(=O)NCc1ccc(C#N)cc1)c1c(F)cc(-c2ccccc2)cc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.48
SLC1A3 P43003 1/20 0.43
SLC1A2 P43004 1/20 0.43
SCN9A Q15858 3/20 0.42
SCN5A Q14524 2/20 0.42
HIF1A Q16665 1/20 0.42
BACE1 P56817 3/20 0.41
PPARA Q07869 1/20 0.41
AKR1C3 P42330 1/20 0.40
CNR2 P34972 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA3 P07451 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39
CACNA1C Q13936 1/20 0.39
CA9 Q16790 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5040804 1.00 PKM (0.48) PKMSLC1A3SLC1A2SCN9ASCN5A
SCHEMBL5037965 0.90 SLC1A3 (0.42) PKMSLC1A3SLC1A2SCN9ASCN5A
SCHEMBL5037967 0.90 SLC1A3 (0.42) PKMSLC1A3SLC1A2SCN9ASCN5A
SCHEMBL5040847 0.88 PKM (0.47) PKMSLC1A3SLC1A2SCN9ASCN5A
SCHEMBL5040855 0.88 PKM (0.47) PKMSLC1A3SLC1A2SCN9ASCN5A
SCHEMBL5041550 0.87 PKM (0.48) PKMSLC1A3SLC1A2SCN9ASCN5A
SCHEMBL5041552 0.87 PKM (0.48) PKMSLC1A3SLC1A2SCN9ASCN5A
SCHEMBL5041197 0.86 PKM (0.43) PKMHIF1ARAB9AEPHX2ALDH1A1
SCHEMBL5037955 0.86 PKM (0.43) PKMSLC1A3SLC1A2SCN9ASCN5A
SCHEMBL5041193 0.86 PKM (0.43) PKMHIF1ARAB9AEPHX2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 PKM 4225/4885SLC1A3 2652/4885SLC1A2 2127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.